A further network modeling of Smad3 target genes, together with Smad3 expression and phosphorylation, and the Smad3 ChIP-seq of the striatum of HD knock-in mice, identified TGF-β/Smad signaling as a core regulator of early gene expression in HD that has therapeutic implications [286]. The gene discussed is TGFB1; the disease is Huntington disease.